<DOC>
	<DOCNO>NCT00998075</DOCNO>
	<brief_summary>The purpose study investigate whether treatment combination capsule Esomeprazole 40 mg Aspirin ( ASA ) 325 mg bioequivalent ( i.e.has effect within body ) medication take separately . Two different form esomeprazole ( tablet capsule ) investigate .</brief_summary>
	<brief_title>Study Comparing Esomeprazole Acetylsalicylic Acid ( ASA ) Combined Together One Capsule Versus These Medications Taken Separately</brief_title>
	<detailed_description />
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Nonsmoking male female within age range 20 50 year Body Mass Index ( BMI = weight/height2 ) great equal 18.5 kg/m2 less equal 29.9 kg/m2 Documented upper gastrointestinal surgery Use proton pump inhibitor bismuth preparation ( e.g . PeptoBismolÂ® ) within 14 day precede screen visit</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>ASA</keyword>
	<keyword>Esomeprazole</keyword>
	<keyword>peptic ulcer disease</keyword>
	<keyword>primary cardiovascular protection</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>